Nominal Variables Tests and Outcome Measures - Lecture 4
Nominal Variables Tests and Outcome Measures - Lecture 4
measures
Without
Diabetes Total
Diabetes
FTO [CC] 1500 8500 10000
0 1
http://www.cebm.net/glossary/
What to do when talking about survival?
Dead due to myocardial infarction Alive Total
INS 5’VNTR [CC] 100 1900 2000
INS 5’VNTR
80 1920 2000
[nonCC]
Total 180 3820 4000
Humans don’t
What is missing?
live forever
Cumulative probability – a way to incorporate
incomplete observations into the analysis
• A multiplication of probabilities of an event occurring on a certain timepoint in an
observation lasting t epochs
• The cumulative probability covers both the probability of an event occurring while taking
into account the observations dropping out of the analysis due to various reasons:
• Surviving past observation end
R – Relapse
D – Death
Converting the probabilities into a database with individual
starting points
R – Relapse
D – Death
Objectives of survival analysis
Estimate time-to-event for a group of individuals, such as time until
second heart-attack (MI) for a group of MI patients.
Censoring:
Subjects are said to be censored if they are lost to follow-up or drop out of the study,
or if the study ends before they die or have an outcome of interest. They are counted
as alive or disease-free for the time they were enrolled in the study. (ci =1 if had the
event; ci = 0 no event by time ti)
Kaplan-Meier curves
• We take the time to event into account rather than just the
event’s presence and group assignment
• The database needs three variables
– Complete observations are ones in whom the event occurred
• They impact survival curves by reducing the estimated probability of survival
Median
survival
time
Individual Censored
observation time observations
A log-rank test creates 2x2 tables at each event time and combines across the tables
It provides a c2 statistic with 1 degree of freedom (for a two groups comparison) and a
p-value.
When p value <0.05 we can conclude that there is a significant difference in the
survival time, e.g. in the treated group compared to untreated one.
Examples on using K-M curves
• Survival estimates can be unreliable toward the end of a study when there are
small numbers of subjects at risk of having an event
0 1
Thank you for your attention